Arbutus Biopharma Corp (ABUS) — Cash Flow Quality Index
Arbutus Biopharma Corp (ABUS) has a Cash Flow Quality Index of -0.05x as of March 2026. Operating cash flow of $-8.11 Million is below net income of $169.69 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ABUS operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Arbutus Biopharma Corp Cash Flow Quality Index (2006–2012)
Historical Cash Flow Quality Index for Arbutus Biopharma Corp across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Arbutus Biopharma Corp.
Annual Cash Flow Quality Index for Arbutus Biopharma Corp (2006–2012)
Year-by-year earnings quality comparison for Arbutus Biopharma Corp.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2012 | 1.11x | $33.27 Million | $29.95 Million | ▲ +865.7% |
| 2006 | -0.15x | $-2.62 Million | $18.08 Million | — |